Variant report
Variant | nsv980520 |
---|---|
Chromosome Location | chr4:166454479-166464670 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:166459248..166460151-chr4:167012754..167013285,2 | K562 | blood: | |
2 | chr4:166457407..166458582-chr4:167012763..167013739,5 | MCF-7 | breast: | |
3 | chr4:166463048..166465958-chr4:166466344..166468402,2 | K562 | blood: | |
4 | chr4:166458088..166458621-chr4:166702621..166703139,2 | MCF-7 | breast: | |
5 | chr4:166458106..166458875-chr4:166702316..166703340,5 | MCF-7 | breast: | |
6 | chr4:166457869..166458829-chr4:166621749..166622649,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565371610 | chr4:166454590-166454591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532582333 | chr4:166454630-166454631 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10004769 | chr4:166454638-166454639 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs566379798 | chr4:166454648-166454649 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185382083 | chr4:166454649-166454650 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs59427259 | chr4:166454674-166454675 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs189204622 | chr4:166454716-166454717 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537238717 | chr4:166454732-166454733 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs17046656 | chr4:166454733-166454734 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs148143287 | chr4:166454782-166454783 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538643413 | chr4:166454789-166454790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374297318 | chr4:166454798-166454799 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553459611 | chr4:166454806-166454807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7664515 | chr4:166454808-166454809 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs7689185 | chr4:166454826-166454827 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs181897065 | chr4:166454875-166454876 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576348746 | chr4:166454885-166454886 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141941871 | chr4:166454887-166454888 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565414508 | chr4:166454909-166454910 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75789332 | chr4:166454927-166454928 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7664890 | chr4:166454935-166454936 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs559441982 | chr4:166454964-166454965 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530432466 | chr4:166455032-166455033 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs386681683 | chr4:166455037-166455038 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs7665408 | chr4:166455038-166455039 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs531043617 | chr4:166455040-166455041 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147339289 | chr4:166455084-166455085 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184882358 | chr4:166455085-166455086 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs538306997 | chr4:166455117-166455118 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7664983 | chr4:166455125-166455126 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs141000794 | chr4:166455167-166455168 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536238800 | chr4:166455180-166455181 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554928520 | chr4:166455230-166455231 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs80150178 | chr4:166455246-166455247 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs189693501 | chr4:166455254-166455255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs558758985 | chr4:166455256-166455257 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144654316 | chr4:166455273-166455274 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs17046676 | chr4:166455306-166455307 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs559789143 | chr4:166455325-166455326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs111711417 | chr4:166455371-166455372 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542190893 | chr4:166455372-166455373 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs57104235 | chr4:166455380-166455381 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs531080390 | chr4:166455382-166455383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552355495 | chr4:166455412-166455413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368004023 | chr4:166455428-166455429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577907462 | chr4:166455429-166455430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139239528 | chr4:166455499-166455500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534061420 | chr4:166455532-166455533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181043735 | chr4:166455567-166455568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565743759 | chr4:166455653-166455654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
intellectual deficit | 22127048 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:166438800-166462000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:166454600-166455400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr4:166457400-166457600 | Enhancers | Colon Smooth Muscle | Colon |
4 | chr4:166458200-166458400 | Enhancers | Colon Smooth Muscle | Colon |
5 | chr4:166461400-166461800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr4:166461400-166462000 | Enhancers | Fetal Intestine Large | intestine |
7 | chr4:166461400-166462200 | Enhancers | Duodenum Mucosa | Duodenum |
8 | chr4:166461400-166462200 | Enhancers | Rectal Mucosa Donor 29 | rectum |
9 | chr4:166461400-166462200 | Enhancers | Osteobl | bone |
10 | chr4:166461400-166462400 | Enhancers | Fetal Intestine Small | intestine |
11 | chr4:166461600-166461800 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
12 | chr4:166461800-166462200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
13 | chr4:166462000-166462200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr4:166462000-166462200 | Flanking Active TSS | Fetal Intestine Large | intestine |
15 | chr4:166462000-166464200 | Weak transcription | Fetal Brain Male | brain |
16 | chr4:166463000-166463400 | Enhancers | Fetal Brain Female | brain |
17 | chr4:166464200-166464800 | Enhancers | Fetal Brain Male | brain |